DexCom had 20 patents in artificial intelligence during Q4 2023. DexCom Inc filed patents in Q4 2023 for monitoring systems with continuous analyte sensors and sensor electronics modules to generate and process analyte measurements for managing hyperglycemia and hypoglycemia. The systems also include methods for continuous analyte measurement of a host’s vascular system for safe and reliable control of insulin delivery based on glycemic risk. GlobalData’s report on DexCom gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
DexCom grant share with artificial intelligence as a theme is 40% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Sensing systems and methods for diagnosing kidney disease (Patent ID: US20230389844A1)
The patent filed by DexCom Inc. describes a monitoring system that includes a continuous analyte sensor generating measurements related to a patient's analyte levels, along with a sensor electronics module to receive and process these measurements. The system can include a continuous potassium sensor to provide potassium measurements, which can be used to predict kidney disease based on trends identified by processing the data. Recommendations for treatment or prevention of kidney disease can be generated based on these predictions, including lifestyle modifications, medication recommendations, interventions, or additional diagnostic testing.
Furthermore, the system can incorporate non-analyte sensors like insulin pumps, accelerometers, or ECG sensors to gather additional patient data for refining the kidney disease prediction. The prediction model can be trained using population data from historical patients with varying kidney disease stages. Additionally, demographic information, food consumption, activity levels, medication history, and other health-related data can be used to enhance the accuracy of the kidney disease prediction. Overall, the system aims to provide personalized insights and recommendations for managing kidney disease based on continuous monitoring and analysis of various health parameters.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
